3-Amino-4-hydroxy-5-nitrobenzenesulfonic acid, 95.0%, 10g

E-Plan phase EPLPH S40x/0.65 objective. Working distance 0.64 mm

ETHYL 2-(AZETIDIN-3-YL)ACETATE TFA, 95%, 2.5g

3-Methylbicyclo[1.1.1]pentane-1-carboxamide, 97%, 250mg

(R)-1-(4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)-N-((R)-1-phenylethyl)ethanamine, 97%, 50mg

3-Hydroxycyclopentanecarbonitrile, 95%, 10g

2-Chloro-5-methoxybenzeneboronic acid, 97.0%, 10g

5-Chloro-3H-[1,2,3]triazolo[4,5-b]pyridine, 95.0%, 1g

Bis(2,2,2-trifluoroethyl) Ether>99.0%(GC)5g

6-Amino-2-benzofuran-1(3H)-one, 97.0%, 5g

N-(4-Bromo-2-chloro-6-methylphenyl)acetamide, 98%, 500mg

Trimethylboroxine (ca. 50% in Tetrahydrofuran)25g

Cis-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-3-carboxylic acid, 95.0%, 1g